Journal article · 2017
Looking Beyond Overall Survival in Ovarian Cancer Clinical Trials
Oncology Times, 39(23), 34 · Published 28 November 2017 · DOI 10.1097/01.cot.0000527893.21568.7c
In brief
“Looking Beyond Overall Survival in Ovarian Cancer Clinical Trials” is a 2017 journal article by Catlin Nalley, published in Oncology Times. OpenAlex counts 0 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- Authors
- 1
Abstract
ovarian cancer; clinical trials: ovarian cancer; clinical trialsNEW YORK CITY—Historically, overall survival (OS) has been considered the primary endpoint in randomized clinical trials of ovarian cancer. This focus was justified by the toxicity of available regimens, the marginal survival benefit of subsequent therapies (second-line and beyond), and the belief that ovarian cancer for the most… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Nalley, C. (2017). Looking Beyond Overall Survival in Ovarian Cancer Clinical Trials. Oncology Times, 39(23), 34. https://doi.org/10.1097/01.cot.0000527893.21568.7c
MLA 9
Nalley, Catlin. “Looking Beyond Overall Survival in Ovarian Cancer Clinical Trials.” Oncology Times, vol. 39, no. 23, 2017, p. 34. https://doi.org/10.1097/01.cot.0000527893.21568.7c.
Chicago
Nalley, Catlin. 2017. “Looking Beyond Overall Survival in Ovarian Cancer Clinical Trials.” Oncology Times 39 (23): 34. https://doi.org/10.1097/01.cot.0000527893.21568.7c.
Harvard
Nalley, C. (2017) ‘Looking Beyond Overall Survival in Ovarian Cancer Clinical Trials’, Oncology Times, 39(23), p. 34. doi:10.1097/01.cot.0000527893.21568.7c.
IEEE
C. Nalley, “Looking Beyond Overall Survival in Ovarian Cancer Clinical Trials,” Oncology Times, vol. 39, no. 23, p. 34, 2017, doi: 10.1097/01.cot.0000527893.21568.7c.
BibTeX
@article{nalley2017looking,
title = {{Looking Beyond Overall Survival in Ovarian Cancer Clinical Trials}},
author = {Nalley, Catlin},
journal = {Oncology Times},
year = {2017},
volume = {39},
number = {23},
pages = {34},
doi = {10.1097/01.cot.0000527893.21568.7c},
url = {https://doi.org/10.1097/01.cot.0000527893.21568.7c}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- ovarian cancer
- clinical trial endpoints
- overall survival
- progression-free survival
- second-line therapy
- third-line therapy
- fourth-line therapy
- treatment toxicity
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Nalley, C. (2017). Looking Beyond Overall Survival in Ovarian Cancer Clinical Trials. Oncology Times, 39(23), 34. https://doi.org/10.1097/01.cot.0000527893.21568.7c
How many times has this paper been cited?
0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Catlin Nalley.
What is the DOI of this paper?
10.1097/01.cot.0000527893.21568.7c, permanently at https://doi.org/10.1097/01.cot.0000527893.21568.7c. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.